Halozyme
HALO
HALO
267 hedge funds and large institutions have $3.53B invested in Halozyme in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 89 increasing their positions, 98 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
9% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 98
1.97% less ownership
Funds ownership: 99.83% → 97.86% (-2%)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
267
Holding in Top 10
5
Calls
$23.6M
Puts
$6.53M
Top Buyers
| 1 | +$50.2M | |
| 2 | +$27.8M | |
| 3 | +$23.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.6M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$33.2M | |
| 3 | -$27.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$17.8M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16M |